Total Payments
$3,813
2024 Payments
$1,349
Companies
39
Transactions
171
Medicare Patients
3,205
Medicare Billing
$546,583
Payment Breakdown by Category
Food & Beverage$3,729 (97.8%)
Education$83.73 (2.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,729 | 167 | 97.8% |
| Education | $83.73 | 4 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ANI Pharmaceuticals, Inc. | $714.16 | 1 | $0 (2024) |
| Amgen Inc. | $441.37 | 24 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $302.65 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $261.67 | 17 | $0 (2024) |
| GENZYME CORPORATION | $243.08 | 12 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $170.96 | 9 | $0 (2022) |
| Travere Therapeutics, Inc. | $143.68 | 7 | $0 (2023) |
| CALLIDITAS THERAPEUTICS US INC. | $130.80 | 6 | $0 (2024) |
| Novo Nordisk Inc | $95.44 | 5 | $0 (2024) |
| Relypsa, Inc. | $88.35 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,349 | 30 | ANI Pharmaceuticals, Inc. ($714.16) |
| 2023 | $554.40 | 31 | Otsuka America Pharmaceutical, Inc. ($92.63) |
| 2022 | $499.48 | 27 | Otsuka America Pharmaceutical, Inc. ($88.17) |
| 2021 | $399.08 | 24 | AstraZeneca Pharmaceuticals LP ($89.08) |
| 2020 | $277.67 | 17 | AKEBIA THERAPEUTICS INC ($70.05) |
| 2019 | $323.65 | 18 | AstraZeneca Pharmaceuticals LP ($72.93) |
| 2018 | $223.38 | 13 | Horizon Pharma plc ($57.92) |
| 2017 | $186.34 | 11 | Keryx Biopharmaceuticals, Inc. ($35.93) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Genetic Disease | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.19 | General |
| 11/13/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $22.07 | General |
| Category: NEPHROLOGY | ||||||
| 11/07/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $714.16 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/06/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Nephrology | ||||||
| 09/20/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Inflammation | ||||||
| 09/18/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Nephrology | ||||||
| 09/03/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Catheter Lock Solution | ||||||
| 08/28/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: NEPHROLOGY | ||||||
| 08/02/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Nephrology | ||||||
| 07/30/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: Genetic Disease | ||||||
| 07/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | Chiesi USA, Inc. | ELFABRIO (Drug) | Food and Beverage | Cash or cash equivalent | $21.98 | General |
| Category: ERT FOR FABRY DISEASE | ||||||
| 06/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Diabetes | ||||||
| 06/05/2024 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Genetic Disease | ||||||
| 06/04/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: Inflammation | ||||||
| 05/24/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $18.84 | General |
| Category: NEPHROLOGY | ||||||
| 05/10/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.37 | General |
| 04/19/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Inflammation | ||||||
| 04/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Cardio-renal | ||||||
| 03/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: DIABETES | ||||||
| 03/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 629 | 1,069 | $226,392 | $105,025 |
| 2022 | 14 | 758 | 1,470 | $282,619 | $130,602 |
| 2021 | 14 | 841 | 1,455 | $299,016 | $151,624 |
| 2020 | 14 | 977 | 1,797 | $347,786 | $159,332 |
Total Patients
3,205
Total Services
5,791
Medicare Billing
$546,583
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 30 | 143 | $78,650 | $37,440 | 47.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 102 | 233 | $29,125 | $13,853 | 47.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 25 | 53 | $26,540 | $11,299 | 42.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 120 | $16,800 | $8,687 | 51.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 110 | 123 | $14,145 | $6,122 | 43.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 51 | 104 | $13,520 | $5,660 | 41.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 49 | 49 | $9,310 | $4,887 | 52.5% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 11 | 22 | $10,450 | $3,856 | 36.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 49 | 83 | $7,055 | $3,195 | 45.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 30 | $4,950 | $2,791 | 56.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $4,830 | $2,545 | 52.7% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 14 | 37 | $5,550 | $2,380 | 42.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 34 | 35 | $5,425 | $2,281 | 42.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 14 | $42.00 | $30.80 | 73.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 33 | 176 | $96,800 | $47,819 | 49.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 140 | 389 | $48,585 | $20,934 | 43.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 28 | 71 | $35,050 | $16,135 | 46.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 82 | 175 | $22,750 | $9,763 | 42.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 66 | 67 | $12,730 | $6,640 | 52.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 95 | $13,300 | $6,232 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 93 | 104 | $11,960 | $4,773 | 39.9% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 23 | 72 | $10,800 | $4,603 | 42.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 69 | 142 | $12,070 | $4,156 | 34.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 40 | 43 | $6,665 | $3,331 | 50.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 22 | 30 | $4,950 | $2,344 | 47.4% |
About Dr. James Visser, MD
Dr. James Visser, MD is a Nephrology healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548353048.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Visser, MD has received a total of $3,813 in payments from pharmaceutical and medical device companies, with $1,349 received in 2024. These payments were reported across 171 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($3,729).
As a Medicare-enrolled provider, Visser has provided services to 3,205 Medicare beneficiaries, totaling 5,791 services with total Medicare billing of $546,583. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Grand Rapids, MI
- Active Since 10/02/2006
- Last Updated 01/17/2020
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1548353048
Products in Payments
- PURIFIED CORTROPHIN GEL (Drug) $714.16
- JYNARQUE (Drug) $302.65
- TAVNEOS (Drug) $226.83
- Veltassa (Drug) $167.40
- FABRAZYME (Biological) $157.11
- Auryxia (Drug) $133.73
- TARPEYO (Drug) $130.80
- ACTHAR (Biological) $128.01
- FARXIGA (Drug) $117.93
- Parsabiv (Drug) $98.73
- AURYXIA (Drug) $93.24
- LOKELMA (Drug) $87.01
- INJECTAFER (Drug) $84.44
- Ozempic (Drug) $80.97
- Kerendia (Drug) $75.90
- Tavneos (Drug) $67.24
- LUPKYNIS (Drug) $65.06
- RAYALDEE (Drug) $60.09
- PROCYSBI (Drug) $57.92
- JARDIANCE (Drug) $53.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Grand Rapids
Dr. Ronald Hofmann, Md, MD
Nephrology — Payments: $10,254
Nephrology $10,254
Dr. Paul Delyria, M.d, M.D
Nephrology — Payments: $5,458
Nephrology $5,458
Dr. Brett Plattner, M.d, M.D
Nephrology — Payments: $3,647
Nephrology $3,647
Dr. Daniel Legault, Md, MD
Nephrology — Payments: $3,145
Nephrology $3,145
Dr. Ramandeep Banga, M.d, M.D
Nephrology — Payments: $2,281
Nephrology $2,281
Dr. Kseniya Filippova, Md, MD
Nephrology — Payments: $2,016
Nephrology $2,016